CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-30 | NIES ALAN S Director | Exercise or conversion · Restricted Stock Units | −4,024 | 0 | ||
| 2022-04-30 | LEFKOWITZ ROBERT J MD Director | Exercise or conversion | +4,024 | 31,030 | ||
| 2022-04-30 | LEFKOWITZ ROBERT J MD Director | Exercise or conversion · Restricted Stock Units | −4,024 | 0 | ||
| 2022-04-30 | DEBBANE RAYMOND Director | Exercise or conversion | +4,024 | 331,545 | ||
| 2022-04-30 | DEBBANE RAYMOND Director | Exercise or conversion · Restricted Stock Units | −4,024 | 0 | ||
| 2022-04-30 | BARKER SAM L Director | Exercise or conversion | +4,024 | 70,315 | ||
| 2022-04-30 | BARKER SAM L Director | Exercise or conversion · Restricted Stock Units | −4,024 | 0 | ||
| 2022-04-30 | Amouyal Philippe Director | Exercise or conversion | +4,024 | 31,030 | ||
| 2022-04-30 | Amouyal Philippe Director | Exercise or conversion · Restricted Stock Units | −4,024 | 0 | ||
| 2022-02-28 | Alexander Kristen VP, Finance and Accounting | Exercise or conversion | +3,200 | 12,200 | ||
| 2022-02-28 | Alexander Kristen VP, Finance and Accounting | Exercise or conversion | +5,400 | 17,600 | ||
| 2022-02-28 | Alexander Kristen VP, Finance and Accounting | Exercise or conversion | +2,700 | 20,300 | ||
| 2022-02-28 | Alexander Kristen VP, Finance and Accounting | Shares withheld for taxes | −3,337 | $2.85 | $10K | 16,963 |
| 2022-02-28 | Alexander Kristen VP, Finance and Accounting | Exercise or conversion · Restricted Stock Units | −3,200 | 0 | ||
| 2022-02-28 | Alexander Kristen VP, Finance and Accounting | Exercise or conversion · Restricted Stock Units | −5,400 | 5,400 | ||
| 2022-02-28 | Alexander Kristen VP, Finance and Accounting | Exercise or conversion · Restricted Stock Units | −2,700 | 5,400 | ||
| 2022-02-28 | Seth Kiernan VP, Chief Commercial Officer | Exercise or conversion | +10,007 | 10,007 | ||
| 2022-02-28 | Seth Kiernan VP, Chief Commercial Officer | Exercise or conversion | +14,834 | 24,841 | ||
| 2022-02-28 | Seth Kiernan VP, Chief Commercial Officer | Exercise or conversion | +5,287 | 30,128 | ||
| 2022-02-28 | Seth Kiernan VP, Chief Commercial Officer | Shares withheld for taxes | −8,261 | $2.85 | $24K | 21,867 |
Page 23 of 27 · 540 trades